Levels of autonomy in FDA-cleared surgical robots: a systematic review

Audrey Lee,Turner S. Baker,Joshua B. Bederson,Benjamin I. Rapoport

DOI: https://doi.org/10.1038/s41746-024-01102-y

IF: 15.2

2024-04-27

npj Digital Medicine

Abstract:The integration of robotics in surgery has increased over the past decade, and advances in the autonomous capabilities of surgical robots have paralleled that of assistive and industrial robots. However, classification and regulatory frameworks have not kept pace with the increasing autonomy of surgical robots. There is a need to modernize our classification to understand technological trends and prepare to regulate and streamline surgical practice around these robotic systems. We present a systematic review of all surgical robots cleared by the United States Food and Drug Administration (FDA) from 2015 to 2023, utilizing a classification system that we call Levels of Autonomy in Surgical Robotics (LASR) to categorize each robot's decision-making and action-taking abilities from Level 1 (Robot Assistance) to Level 5 (Full Autonomy). We searched the 510(k), De Novo, and AccessGUDID databases in December 2023 and included all medical devices fitting our definition of a surgical robot. 37,981 records were screened to identify 49 surgical robots. Most surgical robots were at Level 1 (86%) and some reached Level 3 (Conditional Autonomy) (6%). 2 surgical robots were recognized by the FDA to have machine learning-enabled capabilities, while more were reported to have these capabilities in their marketing materials. Most surgical robots were introduced via the 510(k) pathway, but a growing number via the De Novo pathway. This review highlights trends toward greater autonomy in surgical robotics. Implementing regulatory frameworks that acknowledge varying levels of autonomy in surgical robots may help ensure their safe and effective integration into surgical practice.

health care sciences & services,medical informatics

What problem does this paper attempt to address?

This paper mainly discusses the problem of the mismatch between the increasing level of automation in the field of surgical robots and existing classification and regulatory frameworks. With the advancement of technology, the autonomous capabilities of surgical robots have been continuously enhanced, but the existing classification system does not fully reflect this trend. The researchers propose a new classification system called "Levels of Autonomy in Surgical Robotics (LASR)", which divides the decision-making and execution capabilities of robots into levels 1 to 5, ranging from fully-assisted to fully-autonomous.

The paper systematically reviews all surgical robots approved by the U.S. Food and Drug Administration (FDA) from 2015 to 2023, and finds that most robots are at level 1 (robotic assistance), with a few reaching level 3 (conditionally autonomous). The study also points out that although some robots claim to have machine learning capabilities in their marketing materials, only a few explicitly mention this in FDA official documents.

The current regulatory framework mainly focuses on technical indicators, neglecting the importance of actual developmental benchmarks and human-computer interaction in ensuring the safety of patients and surgeons. As the level of task automation in surgery increases, there is a need for updated regulations to clarify responsibility allocation, such as who should be responsible for the safety of the surgery during automated procedures, and what additional technical capabilities surgeons need to possess.

The results of the paper show that the majority of newly introduced surgical robots are approved through the 510(k) pathway, but there is also a small portion approved through the De Novo pathway, which applies to low-to-moderate risk devices without precedents. In addition, although most surgical robots still require continuous control by surgeons, there are already systems that are beginning to achieve task automation and generate patient-specific strategies.

The paper calls for the establishment of a unified framework tailored to the characteristics of surgical robots to develop reasonable safety and efficacy standards, and promote the regulatory and practical development of this field. This will help ensure that future surgical robots with higher autonomy can be safely and effectively integrated into surgical practice.